Per Soelberg Sørensen

Per Soelberg Sørensen

Professor emeritus, Professor, emeritus


  1. Published

    Early safety and efficacy of fingolimod treatment in Denmark

    Voldsgaard, A., Koch-Henriksen, N., Magyari, M., Sellebjerg, Finn Thorup, Sørensen, Per Soelberg & Oturai, A. B., Jan 2017, In: Acta Neurologica Scandinavica. 135, 1, p. 129-133 5 p.

    Research output: Contribution to journalJournal articleResearch

  2. Published

    Trichurs suis ova theraphy in relapsing multiple sclerosis is safe but without signals of beneficial effect

    Voldsgaard, A., Bager, P., Garde, E., Åkeson, P., Leffers, A. M., Madsen, C. G., Kapel, Christian, Thamsborg, Stig Milan, Roepstorff, A. K., Melbye, M., Siebner, Hartwig Roman, Søndergaard, H. B., Sellebjerg, F. & Sørensen, Per Soelberg, 2015, In: Multiple Sclerosis Journal. 21, 13, 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis

    Vollmer, T. L., Sørensen, Per Soelberg, Selmaj, K., Zipp, F., Havrdova, E., Cohen, J. A., Sasson, N., Gilgun-Sherki, Y., Arnold, D. L. & BRAVO Study Group, B. S. G., Apr 2014, In: Journal of Neurology. 261, 4, p. 773-783 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Cerebral blood flow in patients with normal-pressure hydrocephalus before and after shunting

    Vorstrup, S., Christensen, J., Gjerris, F., Sørensen, Per Soelberg, Thomsen, A. M. & Paulson, Olaf B., Mar 1987, In: Journal of Neurosurgery. 66, 3, p. 379-87 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Cortical N-acetyl aspartate is a predictor of long-term clinical disability in multiple sclerosis

    Wu, X., Hanson, L. G., Skimminge, A., Sørensen, Per Soelberg, Paulson, Olaf B., Mathiesen, H. K. & Blinkenberg, M., Aug 2014, In: Neurological Research. 36, 8, p. 701-708 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Population Pharmacokinetic–B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple Sclerosis

    Yu, H., Graham, G., David, O. J., Kahn, J. M., Savelieva, M., Pigeolet, E., Das Gupta, A., Pingili, R., Willi, R., Ramanathan, K., Kieseier, B. C., Häring, D. A., Bagger, M. & Sørensen, Per Soelberg, 2022, In: CNS Drugs. 36, 3, p. 283-300 18 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1...22 23 24 25 26 Next

ID: 11025